Patients How prioritising sustainability efforts yields long-term gro... The pharmaceutical industry is at a pivotal juncture.
Patients Why informed patient consent is vital for successful clinica... Informed consent is vital for any clinical trial.
Patients A methodological approach in patient insights to discover th... When patients are diagnosed with a disease, they embark on a journey that is an emotional rollercoaster.
Patients Cell and gene therapies and the tricky question of patient s... Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution?
Patients Sustainable innovation for patients, people, and planet Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director of public affairs and communications at C
Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
